BOZEN, Italy, August 10
- Strategic Partnership Announced With Health Robotics
Health Robotics today announced that it has signed an exclusive five-yearstrategic partnership with McKesson for Health Robotics' CytoCare Robot. Theagreement enables McKesson to achieve its goal of safely, accurately andcost-effectively automating the preparation of Oncology I.V. admixtures.
"We are very pleased to have been chosen by Health Robotics as theirexclusive CytoCare partner in our core markets of the United States andCanada", stated David Souerwine, President, McKesson Automation. "CytoCare,a-one-of-its-kind solution, represents an ideal complement to ROBOT-Rx(R) andMedCarousel(R) technologies, and our entire suite of Automation solutions."
McKesson believes that CytoCare has the potential to become the goldstandard for Oncology I.V. admixtures in North America, equally protectingclinicians and patients. The successful installations of the CytoCare Robotin the United States, including the University of Colorado Hospital inDenver, show synergies between CytoCare and both McKesson Automation andother McKesson Provider Technologies market-leading solutions.
"McKesson is the ideal partner for Health Robotics in North America dueto its commitment to medication safety, company stability, market footprint,world-class service infrastructure, and complementary oral medicationautomation technologies. I was extremely impressed to see their manufacturingand customer services operations in Pittsburgh; they are exactly whatCytoCare customers need in North America: a knowledgeable, committed,resourceful, and customer-focused organization. This is precisely what HealthRobotics requires at this moment in time to take CytoCare to the next levelof market acceptance and customer-service focus in North America. I'm surethis is just the beginning of a long-term partnership expanding intomanufacturing and other fields of I.V. Robotics Automation", stated WernerRainer, Chairman and CEO of Health Robotics.
About Health Robotics:
Health Robotics is the global leading supplier of life-criticalintra-venous medication preparation, compounding, and dispensing Robots,providing healthcare facilities in four continents with robotics technologyand software automation solutions. The world-leading solutions CytoCare[hazardous IVs], i.v.STATION [non-hazardous IVs], i.v.SOFT [workflow engine]and the future development of TPNstation, have and will greatly contribute toease global hospitals' growing pressures to improve patient safety throughthe effective and efficient production of sterile, accurate, andready-to-administer IVs, to eliminate life-threatening drug-exchange errors,to decrease other medication errors and sterility risks, and to work moreefficiently, increase throughput, reduce waste, and contain costs. For moreinformation, visit http://www.health-robotics.com
McKesson Corporation, currently ranked 15th on the FORTUNE 500, is ahealthcare services and information technology company dedicated to helpingits customers deliver high-quality healthcare by reducing costs, streamliningprocesses, and improving the quality and safety of patient care. McKesson hasbeen in continuous operation for more than 175 years, making it thelongest-operating company in healthcare today. Over the course of itshistory, McKesson has grown by providing pharmaceutical and medical-surgicalsupply management across the spectrum of care; healthcare informationtechnology for hospitals, physicians, homecare and payors; hospital andretail pharmacy automation; and services for manufacturers and payorsdesigned to improve outcomes for patients. For more information, visithttp://www.mckesson.comFor additional information, please contact: Health Robotics S.r.l. Gaspar G. DeViedma Altmanstrasse 9A, Bozen, Sud-Tyrol, I-39100 USA: +1-609-980-7976 EUROPE: +39-346-963-4934 firstname.lastname@example.org McKesson Corporation Clay Courville Vice President, Marketing +1-724-741-8111 email@example.com
SOURCE Health Robotics